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It has been suggested that Nogo-A, a myelin-associated protein, could play a role in the
pathogenesis of schizophrenia and that Nogo-A-deficient rodents could serve as an animal
model for schizophrenic symptoms. Since changes in brain laterality are typical of schiz-
ophrenia, we investigated whether Nogo-A-deficient rats showed any signs of disturbed
asymmetry in cortical N -methyl-D-aspartate (NMDA) receptor–nitric oxide synthase (NOS)
pathway, which is reported as dysfunctional in schizophrenia. In particular, we measured
separately in the right and left hemisphere of young and old Nogo-A-deficient male rats
the expression of NMDA receptor subunits (NR1, NR2A, and NR2B in the frontal cortex)
and activities of NOS isoforms [neuronal (nNOS), endothelial (eNOS), and inducible (iNOS)
in the parietal cortex]. In young controls, we observed right/left asymmetry of iNOS activ-
ity and three positive correlations (between NR1 in the left and NR2B laterality, between
NR2B in the right and left sides, and between NR1 in the right side and nNOS laterality).
In old controls, we found bilateral decreases in NR1, an increase in NR2B in the right side,
and two changes in correlations in the NR1–nNOS pathway. In young Nogo-A-deficient
rats, we observed an increase in iNOS activity in the left hemisphere and two changes
in correlations in NR1–nNOS and NR2A–eNOS, compared to young controls. Finally, we
revealed in old Nogo-A-deficient animals, bilateral decreases in NR1 and one change in
correlation between eNOS–iNOS, compared to old controls. Although some findings from
schizophrenic brains did not manifest in Nogo-A-deficient rats (e.g., no alterations in NR2B),
others did (e.g., alterations demonstrating accelerated aging in young but not old animals,
those occurring exclusively in the right hemisphere in young and old animals and those
suggesting abnormal frontoparietal cortical interactions in young animals).
Keywords: brain laterality, animal model of schizophrenia, aging, myelin-associated protein, cortex
INTRODUCTION
It has been suggested that the lateralization of the human brain, i.e.,
differences between the right (R) and left (L) hemisphere,underlies
hemispheric specialization that can also be observed biochemi-
cally. Biochemical laterality appears to be a basis of volumetric or
functional asymmetry; however, direct relationships among them
are still unclear. Brain asymmetry is moderately changed during
normal aging and more markedly in neurodegenerative disor-
ders like Alzheimer disease or in neurodevelopmental diseases like
schizophrenia (for a review, see Toga and Thompson, 2003). Our
previous studies suggested a high sensitivity of lateral correlation
analyses in revealing subtle links among the biochemical pathways.
We therefore recommended their use in animal models of various
diseases that are accompanied by alterations in brain asymmetry.
Knowledge of disease-mediated changes occurring in the human
R and L hemisphere separately as well as that of brain lateralization
of applied control animals (there are differences between mice and
rats and also among various rodent strains) is necessary in vali-
dating animal models in this way (Krištofiková et al., 2004, 2008,
2010). Moreover, we have repeatedly found a very similar degree of
brain asymmetry on a biochemical level in the hippocampus and
cortex, two of the most asymmetrical brain regions (Krištofiková
et al., 2010).
The biological basis of schizophrenia is still unknown, but
many studies have indicated that oligodendroglial dysfunction
with subsequent abnormalities in myelin maintenance and repair
can contribute to the pathogenesis of this major psychiatric disor-
der (Davis et al., 2003). Myelin-associated proteins and especially
the myelin-associated glycoprotein Nogo-A (encoded by the RTN4
gene located on chromosome 2p16.1 and expressed in oligoden-
drocytes or neurons) and its glycosylphosphatidylinositol-linked
Nogo-66 receptor 1 (encoded by the RTN4R gene located on
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chromosome 22q11 and expressed on the surface of neurons or
fibroblasts) are important for cellular remodeling. Nogo-A inhibits
neurite outgrowth, and alters endothelial and smooth muscle
cell migration and adhesion (Dodd et al., 2005). Postmortem or
genetic studies report an involvement of Nogo-A (Coon et al.,
1998; Shaw et al., 1998; Novak et al., 2002; Tan et al., 2005; Novak
and Tallerico, 2006; Jitoku et al., 2011) or its receptor (Sinibaldi
et al., 2004; Hsu et al., 2007; Budel et al., 2008) in schizophre-
nia; however, changes such as varying Nogo-A mRNA levels in the
autoptic frontal cortices of psychotic patients are not marked, in
contrast to those in Nogo-C mRNA (Novak and Tallerico, 2006).
On the other hand, Nogo-A knock-out animals have some
intermediate phenotypes resembling disorders of neurodevel-
opmental origin, such as schizophrenia. Deletion of Nogo-
A increases the motility of embryonic forebrain-derived neu-
rospheres and decreases the accumulation of migrating neuronal
precursors in the newborn cortex (Mathis et al., 2010). However,
the changes in the mature brain tissue are subtle (e.g., there is
significantly increased neurite outgrowth in spinal cord extracts,
but no changes in gross brain anatomy, extracellular matrix mark-
ers, glial markers, and oligodendrocytes morphology; see Simonen
et al., 2003). Nevertheless, young adult Nogo-A knock-out rodents
show schizophrenia-like abnormalities in behavioral tests (e.g.,
deficient sensorimotor gating, disrupted latent inhibition, per-
severative behavior, and increased sensitivity to the locomotor
stimulating effects of amphetamine) and in neurochemical analy-
sis (e.g., altered monoaminergic transmitter levels and changes
in dopamine D2 receptor levels in striatal and limbic regions)
(see Willi et al., 2010; Tews et al., 2013). A recent study reviewed
data from various animals displaying deficient Nogo-A and/or its
receptor, and suggested that schizophrenia-like abnormalities were
based on deregulated brain connectivity (Willi and Schwab, 2013).
Our previous studies focused on lateral alterations in the lev-
els of the N -methyl-d-aspartate receptor (NMDAR) subunit NR1
and nitric oxide synthase (NOS) in postmortem brains of schiz-
ophrenic patients compared to non-psychotic controls. We found
no pronounced laterality in mRNA/protein expression of NR1 in
the hippocampi of the controls, but a significant drop in NR1
expression in the L side of psychotic men (Vrajová et al., 2010).
Regarding the activities or expressions of the NOS isoforms, we
observed no asymmetry in neuronal (nNOS), marked R/L asym-
metry in endothelial (eNOS, dominance in the R side was observed
especially in its activity) and marked L/R asymmetry in inducible
(iNOS, dominance in the L side was found exclusively in its
activity) isoforms in the hippocampi of controls. In people with
schizophrenia, we found more marked increases in nNOS/iNOS
activity (but not in their expression) in the R than L hemisphere
(Krištofiková et al., 2008).
N -methyl-d-aspartate receptors are associated with NOS iso-
forms through a postsynaptic density protein and a stimula-
tion of the receptors activates synthesis of nitric oxide through
the nNOS/eNOS/iNOS isoforms. Functional interactions between
NR1 subunits and nNOS (as well as between NR2A/2B and the
other NOS enzymes) were proposed (e.g., Kamida et al., 2007). In
the brain of schizophrenic patients, there was a drop in the NR1
subunit mRNA level in the dentate gyrus (Gao et al., 2000), but
no significant changes in NR1 protein amounts in the superior
temporal cortex (Nudmamud-Thanoi and Reynolds, 2004). For
the NR2A subunit, no changes in mRNA expression in the ante-
rior cingulate cortex (Woo et al., 2004) or in the hippocampal
subregions (Gao et al., 2000) were observed. On the other hand,
alterations in the expression of the NR2B subunit were clearly
apparent in schizophrenia. Namely, increases in NR2B mRNA con-
centrations in hippocampal CA2 and CA3 (Gao et al., 2000), and
the elevation of NR2B protein levels in the thalamus (Clinton
and Meador-Woodruff, 2004; Clinton et al., 2006) were found.
Some studies have reported associations between the NR2B gene
and schizophrenia (e.g., Li and He, 2007), supporting a role of
NR2B gene polymorphisms in language lateralization (Ocklen-
burg et al., 2011). Moreover, changes in the postsynaptic density
protein, e.g., in the dorsomedial thalamus (Clinton and Meador-
Woodruff, 2004; Clinton et al., 2006), support a dysfunction of the
NMDAR-NOS pathway in schizophrenia.
The aims of the study were to determine the expression of the
NR1/NR2A/NR2B subunits and activities of nNOS/eNOS/iNOS
isoforms separately in the R and L cortex of young and old
Nogo-A-deficient rats, as well as to validate the animal model of
schizophrenia by evaluating alterations in brain laterality.
MATERIALS AND METHODS
ANIMALS
Nogo-A-deficient transgenic animals were generated using
microRNA interference (for more details, see Tews et al., 2013).
Experiments were performed on young (3–5 months) and old
(10–12 months) Nogo-A-deficient Sprague-Dawley rats or age-
matched controls. All rats were housed in groups of two under
a 12-h light/dark cycle. Food (standard pellet diet) and water
were available ad libitum. All experiments were carried out in
accordance with the Animal Protection Law 246/1992 and the
Regulation 419/2012 (Czech Republic) concerning the use of
experimental animals, based on NIH guidelines and EU directives
(2010/63/EU).
TISSUE SAMPLING
Rats were sacrificed by cervical dislocation, decapitated, and the
brains rapidly removed. The frontal and parietal cortices were dis-
sected, weighed, packed in aluminum foil, and frozen at −40ºC
until assayed (no more than 2 weeks later).
EXPRESSION OF THE NMDAR SUBUNITS NR1, NR2A, AND NR2B BY
WESTERN BLOTTING
The frontal cortices were homogenized in 1.0 mL of lysis buffer
(320 mM sucrose; 10 mM Tris, pH 7.4; 0.2 mM EDTA; 2 mM
PMSF; 1 mM 2-mercaptoethanol; and a cocktail of protease
inhibitors, Sigma). Crude synaptosomal (P2) fractions were iso-
lated from homogenates and resuspended in a loading buffer
(63 mM Tris; 10% glycerol; 2% SDS; 5% 2-mercaptoethanol; and
0.01% bromophenol blue). The protein concentration was deter-
mined by the Bradford method using bovine serum albumin
(BSA) as the standard (Bio-Rad, USA). The resuspended mate-
rial was subjected to electrophoresis in the 7.5% polyacrylamide
gel (Criterion Cell, Bio-Rad, USA), followed by electroblotting in
the Criterion blotter (Bio-Rad, USA). Non-specific binding was
blocked with 3% BSA dissolved in TBS-T buffer. Blots were incu-
bated overnight with anti-NMDAR1 (1:100; Millipore, USA) or
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for 2 h with anti-NMDAR2A/2B (1:500; Millipore, USA) primary
antibody. For loading control, blots were treated with an anti-
α-tubulin antibody (1:1000; Exbio, CZ) for 1 h. Then, the blots
were washed in TBS-T buffer and incubated for 1 h with a horse-
radish peroxidase-conjugated secondary antibody (1:3000; Dako,
Denmark). Detections were performed with a chemiluminescent
substrate (Pierce, USA) and evaluated by the Gel Doc Analysis
system (Bio-Rad, USA).
ACTIVITIES OF nNOS, eNOS, AND iNOS
The parietal cortices were homogenized (1:10) in homogenization
buffer (1 mM EGTA, 1 mM dithiothreitol, 20 mM HEPES, 0.32 M
sucrose, 14.6µM pepstatin, and 21µM leupeptin, pH= 7.4) and
the resulting homogenates centrifuged at 1200 g for 10 min at
4°C. Supernatants were added to the reaction buffer [homoge-
nization buffer containing also 200µM β-nicotinamide adenine
dinucleotide phosphate, 50µM tetrahydrobiopterin, and 4.6µM
[14C]arginine (PerkinElmer)] and incubated for 30 min at 37°C.
Some samples also contained 1µM CaCl2 (nNOS and eNOS)
and specific inhibitors (1 mM spermidine for nNOS, 190 µM
Nω-nitro-l-arginine methyl ester for nNOS/eNOS, and 1 mM
aminoguanidine for iNOS, all from Sigma). Final protein concen-
trations determined by the Bradford method equaled 0.5 mg/mL
in all incubation mixtures. The reaction was terminated by adding
the stop buffer (30 mM HEPES, 3 mM EDTA, pH= 5.5) and by
rapid cooling. DOWEX 50WX8-200 (Sigma) was used to separate
citrulline from arginine, in accordance with our previous study
(Krištofiková et al., 2008).
STATISTICAL ANALYSIS
The BMDP statistical software (non-parametric Kruskal–Wallis
test for global analysis and Mann–Whitney–Wilcoxon test for pair-
wise comparisons) or SigmaStat statistical software (Spearman
rank order correlation) were used. Differences between correla-
tion coefficients were evaluated using a Rao test based on the
Fisher Z -transformation. The index of laterality [(L−R)/(L+R)]
was calculated to estimate differences between the R and L sides.
The index is limited to zero when all the values are not later-
alized (marked asymmetry was defined in this study by indexes
>±0.100) or when the numbers of markedly R/L (dominance
of the R side) and L/R (dominance of the L side) animals are
approximately equal. Data in the tables are presented as the
means± SEM.
RESULTS
Results in Table 1 demonstrate no pronounced laterality in the
expression of the NR1, NR2A, and NR2B subunits in the frontal
cortex of young Sprague-Dawley male rats. In old compared to
young controls, we observed a significant bilateral reduction in
NR1 expression (to 94% in the R and to 89% in the L side, both
compared to the corresponding hemisphere of the young con-
trols), no changes in NR2A expression and a significant increase
in NR2B expression (to 108%) only in the R side of the brain. We
also did not find significant changes in NMDAR subunit expres-
sion in young Nogo-A-deficient rats compared to the age-matched
control group. In old Nogo-A-deficient rats, we observed bilateral
increases in NR1 subunit levels (to 106% in the R and to 113%
Table 1 | NR1, NR2A, and NR2B subunit expression.
Groups n R L (L−R)/(L+R)
NR1
Young controls 10 1.031±0.007 1.036±0.008 +0.002±0.004
Young NOGO 9 1.044±0.007 1.055±0.008 +0.005±0.006
Old controls 9 0.972±0.018** 0.924±0.035** −0.028±0.017
Old NOGO 8 1.032±0.023+ 1.047±0.021++ +0.007±0.013
Kruskal–Wallis χ2(3)=12.36 χ2(3)=18.48 χ2(3)=4.45
p=0.0062 p=0.0004 p=0.2169
NR2A
Young controls 10 1.198±0.007 1.198±0.011 +0.000±0.003
Young NOGO 9 1.198±0.020 1.193±0.017 −0.002±0.007
Old controls 9 1.188±0.015 1.177±0.018 −0.007±0.005
Old NOGO 8 1.214±0.015 1.217±0.015 +0.010±0.004
Kruskal–Wallis χ2(3)=1.27 χ2(3)=2.52 χ2(3)=6.34
p=0.7367 p=0.4719 p=0.0963
NR2B
Young controls 10 0.876±0.017 0.871±0.012 −0.002±0.004
Young NOGO 9 0.897±0.010 0.900±0.020 +0.001±0.009
Old controls 9 0.945±0.013** 0.887±0.030 −0.034±0.018
Old NOGO 8 0.902±0.033 0.864±0.058 −0.028±0.030
Kruskal–Wallis χ2(3)=9.01 χ2(3)=2.20 χ2(3)=4.32
p=0.0291 p=0.5312 p=0.2288
Means±SEM, NOGO – Nogo-A-deficient rats.
Mann–Whitney–Wilcoxon test was calculated with respect to young (**p<0.010)
or old (+p<0.050, ++p<0.010) controls.
in the L side, both compared to the corresponding hemisphere
of the old controls), but no changes in NR2A or NR2B subunit
expression compared to the old control group.
Table 2 shows no pronounced asymmetry in nNOS and eNOS
activities, but a strong R/L asymmetry of iNOS activity in the
parietal cortex of young controls. In the old controls, no sig-
nificant differences in the activities of all synthases were found
when compared to corresponding hemispheres of young controls.
However, bilateral increases in nNOS (to 117 and 123% in the R
and L sides, respectively) and bilateral decreases in eNOS (to 71
and 82% in the R and L sides, respectively) were observed. More-
over, the shift from the marked R/L to L/R asymmetry of iNOS
was striking (see the drop to 29% in the R and the increase to
245% in the L side, Mann–Whitney–Wilcoxon test for indexes of
laterality between young and old rats; p= 0.1350). In young Nogo-
A-deficient rats, there were no changes in nNOS or eNOS activities
compared to age-matched controls. On the other hand, the results
of the Mann–Whitney–Wilcoxon tests supported the significant
increase of iNOS activity to 351% in the L side of Nogo-A-deficient
rats despite the insignificant results of the global Kruskal–Wallis
test. We did not observe pronounced alterations in old Nogo-
A-deficient rats compared to age-matched controls; however, the
shift from L/R asymmetry in old controls to R/L asymmetry in
old Nogo-A-deficient rats regarding iNOS activity was again strik-
ing (i.e., the increase to 290% in the R but a drop to 47% in
the L side, Mann–Whitney–Wilcoxon test for indexes of laterality:
p= 0.2808).
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Table 2 |The activities of nNOS, eNOS, and iNOS.
Groups n R L (L−R)/(L+R)
nNOS
Young controls 10 1141.0±101.2 1146.6±86.0 +0.007±0.039
Young NOGO 9 1125.4±39.9 1100.8±75.2 −0.018±0.025
Old controls 9 1335.4±153.4 1413.3±167.5 +0.045±0.059
Old NOGO 8 1252.4±175.3 1220.3±161.5 +0.000±0.055
Kruskal–Wallis χ2(3)=4.66 χ2(3)=4.16 χ2(3)=1.16
p=0.1983 p=0.2442 p=0.7628
eNOS
Young controls 10 829.7±109.8 729.9±138.8 −0.086±0.079
Young NOGO 9 830.6±146.4 788.2±145.2 −0.034±0.069
Old controls 9 586.9±98.7 600.6±102.6 +0.028±0.051
Old NOGO 8 558.7±107.3 450.8±91.1 −0.053±0.140
Kruskal–Wallis χ2(3)=3.60 χ2(3)=2.67 χ2(3)=0.56
p=0.3077 p=0.4462 p=0.9046
iNOS
Young controls 10 34.4±13.4 12.5±7.2 −0.405±0.209
Young NOGO 9 41.0±17.5 43.9±13.5* +0.110±0.266
Old controls 9 10.0±5.2 30.6±13.9 +0.114±0.309
Old NOGO 8 29.0±9.5 14.5±7.0 −0.281±0.136
Kruskal–Wallis χ2(3)=3.65 χ2(3)=4.98 χ2(3)=4.33
p=0.3018 p=0.1732 p=0.2276
Means±SEM, NOGO – Nogo-A-deficient rats.
Mann–Whitney–Wilcoxon test was calculated with respect to young controls
(*p<0.050).
Results of the correlation analyses performed on young con-
trol rats (data are shown in Tables 3 and 4) supported links: (i)
among the subunits of NMDAR (after a Bonferroni correction,
two significant positive correlations were found, between NR1 in
the L side and laterality of NR2B, and between NR2B in the R and
L sides); and (ii) among the subunits and synthases (one signifi-
cant positive correlation was found after a Bonferroni correction
between NR1 in the R side and laterality of nNOS). A comparison
of correlations from 10 young and 9 old control rats is presented
in Table 3. The table shows all significant results with regard to the
Rao test; however, only two significant age-related changes were
found after the Bonferroni correction. First, there was a significant
shift from a positive correlation in young to a negative correla-
tion in old controls between the NR1 subunit in the R side and
nNOS laterality. Second, there was a significant shift from a neg-
ative correlation in young to a positive correlation in old controls
between the NR1 subunit in the L side and nNOS activity in the
R side. Finally, a comparison of the correlation data from 9 young
Nogo-A-deficient rats (and 10 age-matched controls) and 8 old
Nogo-A-deficient rats (and 9 corresponding controls) is given in
Table 4. As in Table 3, all significant results based on the Rao test
are presented. In young Nogo-A-deficient rats, when compared
to the age-matched controls, we observed two significant changes
after a Bonferroni correction. First, there was a shift from a negative
correlation in control to a positive correlation in Nogo-A-deficient
rats between the NR1 subunit in the L side and nNOS activity in
the R side (similar to that seen with normal aging). Second, there
was a significant shift from a negative correlation in control to a
Table 3 |The result of correlation analysis performed on young and old
control rats.
Parameters Young controls Old controls Rao p
CC p CC p
NR1 R×nNOS laterality +0.830 <0.001* −0.762 0.012 <0.001*
NR1 R× iNOS L −0.350 0.309 +0.714 0.025 0.023
NR1 L×NR2B R −0.612 0.054 +0.450 0.204 0.032
NR1 L×NR2B laterality +0.842 <0.001* −0.133 0.709 0.014
NR1 L×nNOS R −0.770 0.007 +0.583 0.087 0.002*
NR1 L×nNOS L −0.648 0.038 +0.433 0.223 0.026
NR1 laterality×nNOS L −0.770 0.007 +0.567 0.099 0.003
NR2A R×eNOS R −0.467 0.160 +0.450 0.204 0.075
NR2A R× iNOS laterality +0.720 0.016 −0.443 0.204 0.013
NR2A L×eNOS R −0.491 0.137 +0.633 0.058 0.021
NR2A L× iNOS laterality +0.603 0.060 −0.523 0.138 0.022
NR2A laterality×nNOS
laterality
−0.382 0.258 +0.686 0.036 0.026
NR2B R×NR2B L +0.903 <0.001* +0.467 0.186 0.078
NR2B L×NR2B laterality −0.430 0.199 +0.683 0.036 0.020
nNOS R× iNOS R −0.717 0.016 +0.365 0.308 0.021
Spearman rank order correlation was first performed on young and old controls,
and subsequently particular correlation coefficients (CC) were compared using
the Rao test. Finally, *Bonferroni correction was performed.
positive correlation in Nogo-A-deficient rats between NR2A and
eNOS, both in the R side (again similar to that observed in normal
aging; however, this was not statistically significant in relation to
aging: p= 0.0749, data not shown). Moreover, we found a marked
shift from an insignificant correlation in old controls to a signif-
icantly positive correlation in old Nogo-A-deficient rats between
the activities of eNOS and iNOS in the R side.
DISCUSSION
NMDAR SUBUNITS AND NOS ISOFORMS IN THE CORTEX OF CONTROL
SPRAGUE-DAWLEY RATS AND EFFECTS OF NORMAL AGING
Our results demonstrated no pronounced differences in NR1,
NR2A, and NR2B expression between the R and L sides of the
frontal cortex in young adult Sprague-Dawley male rats (Table 1).
Moreover, no individual young markedly lateralized (defined by
an index of laterality greater than ±0.100) rat was identified.
No asymmetrical differences in nNOS or eNOS activity were
observed globally; however, in contrast to the NMDAR subunits,
we found some lateralized individuals [namely, one-third of ani-
mals displayed marked R/L asymmetry of globally unlateralized
nNOS/iNOS, one-third presented opposite L/R laterality, and only
one-third was unlateralized, in accordance with our previous study
(Krištofiková et al., 2010)]. On the other hand, young Sprague-
Dawley males displayed pronounced R/L laterality in iNOS activ-
ity, similar to Wistar and Long Evans strains (Krištofiková et al.,
2010). These results could be hypothetically interpreted as a brain
laterality based on asymmetries in expression/activity of various
enzymes, receptors or transporters (see Krištofiková et al., 2004,
2010), but not in NMDAR subunit expression. Our correlation
analysis suggesting possible asymmetric links between NR1 and
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Table 4 |The results of correlation analysis performed on Nogo-A-deficient rats and corresponding controls.
Parameters Groups Controls NOGO Rao p
CC p CC p
SUBUNITS VS. SUBUNITS
NR1 R×NR2A L Young −0.636 0.043 +0.483 0.169 0.022
NR1 R×NR2B R Young −0.442 0.185 +0.833 0.002* 0.003
NR1 R×NR2B L Young −0.491 0.137 +0.667 0.043 0.016
NR1 L×NR2B laterality Young +0.842 <0.001* +0.017 0.948 0.030
NR2A R×NR2B L Old −0.333 0.356 +0.667 0.059 0.046
NR2B L×NR2B laterality Young −0.430 0.199 +0.617 0.067 0.034
SYNTHASES VS. SYNTHASES
nNOS R×nNOS laterality Young −0.697 0.022 +0.393 0.264 0.022
nNOS R× iNOS R Young −0.717 0.016 +0.218 0.550 0.044
nNOS L× iNOS R Young −0.498 0.126 +0.628 0.058 0.021
eNOS R× iNOS R Old −0.091 0.809 +0.976 <0.001* <0.001*
iNOS R× iNOS L Old −0.343 0.331 +0.832 0.005 0.007
SUBUNITS VS. SYNTHASES
NR1 R×nNOS laterality Young +0.830 <0.001* −0.402 0.264 0.004
NR1 R× iNOS laterality Old +0.541 0.124 −0.756 0.021 0.006
NR1 L×nNOS R Young −0.770 0.007 +0.583 0.087 0.002*
NR1 L×nNOS L Young −0.648 0.038 +0.400 0.264 0.032
NR1 laterality×nNOS L Young −0.770 0.007 +0.133 0.709 0.038
NR1 laterality× iNOS R Old +0.785 0.009 −0.439 0.206 0.008
NR1 laterality× iNOS laterality Old −0.674 0.043 +0.708 0.037 0.003
NR2A R×eNOS R Young −0.467 0.160 +0.883 <0.001* <0.001*
NR2A R×eNOS L Young −0.358 0.292 +0.683 0.036 0.030
NR2A R× iNOS L Young +0.798 0.004 −0.167 0.643 0.023
NR2A R× iNOS laterality Young +0.720 0.016 −0.294 0.407 0.030
NR2A L×eNOS R Young −0.491 0.137 +0.600 0.077 0.027
NR2A L×nNOS R Old −0.050 0.878 −0.857 0.002* 0.033
NR2B laterality×nNOS L Old −0.683 0.036 +0.311 0.423 0.045
Spearman rank order correlation was first performed on Nogo-A-deficient rats and on corresponding controls. Particular correlation coefficients (CC) were then
compared by the Rao test. Finally, a *Bonferroni correction was performed.
NR2B (Table 3, the positive correlation between NR1 in the L
side and NR2B laterality and between NR2B in the R and L sides)
and between NR1 and nNOS (Table 3, the positive correlation
between NR1 in the R side and nNOS laterality) thus could reflect
complicated regulatory mechanisms occurring between the two
hemispheres, rather than just L-R lateralization. However, the sit-
uation may not be so simple. It is known that NR2B expression
is equal in homogenates, but asymmetrical in synaptic fractions
isolated separately from the R and L mouse hippocampus (L/R
dominance; Kawakami et al., 2003). Thus, it is suggested that pos-
sible lateralization of NMDAR subunits could be associated with
their allocations at the synaptic level.
In relation to normal aging, we observed bilateral decreases in
NR1, no alterations in NR2A and a significant increase in NR2B
exclusively in the R side of the frontal cortex of old compared to
young control rats (Table 1). Although many studies have reported
age-related decreases in the expression of NMDAR subunits in the
rat/mouse cortex or hippocampus (e.g., Magnusson et al., 2002),
our data supported it only in the case of the NR1 subunit. The dis-
crepancy observed between NR2A and NR2B expression could be
explained by their transient moderate increases in 10-month-old
animals followed by significant drops in 30-month-old animals
(Magnusson et al., 2002). Similarly, we did not find significant
age-related changes in the activities of NOS isoforms in the pari-
etal cortex (Table 2). However, there were moderate changes in old
control rats that were very similar to those in Wistar/Long Evans
strains (the increases in nNOS/iNOS especially in the L side and
the bilateral decreases in eNOS; Krištofiková et al., 2010). There-
fore, it appears that our old Sprague-Dawley controls were still
relatively young to manifest pronounced age-related changes in
their NMDAR subunits expression, except NR1.
Age-related changes in human brain laterality are based on a
higher vulnerability of the L, i.e., dominant in the majority of cases,
than of the R hemisphere to aging processes (Toga and Thomp-
son, 2003). Previously, we noted similar asymmetrical changes
in rat brains; however, they were subtle (although significant)
and difficult to detect, even in very old animals (Krištofiková
et al., 2010). In this study, although we observed a significant
increase in NR2B expression exclusively in the R side, the statistical
analysis using corresponding indexes of laterality did not support
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significant changes in brain asymmetry (Table 1, Kruskal–Wallis
test: p= 0.2288; Mann–Whitney–Wilcoxon between the two con-
trol groups: p= 0.0864). Likewise, although the changes in iNOS
activity of old Sprague-Dawley rats were similar to those of old
Wistar/Long Evans rats (i.e., the drop in the R and the increase in
the L side; Krištofiková et al., 2010), the statistical analysis based
on corresponding indexes of laterality did not support significant
changes again (Table 2, Kruskal–Wallis test: p= 0.2276; Mann–
Whitney–Wilcoxon between the two control groups: p= 0.1350).
Therefore, we believe that our results indicating significant asym-
metrical alterations in the NR1–nNOS pathway during aging
(Table 3, two significant shifts: from a positive to a negative corre-
lation between NR1 in the R side and nNOS laterality; and from
a negative to a positive correlation between NR1 in the L and
nNOS in the R side) should be interpreted as normal aging-evoked
disruption of regulatory mechanisms occurring between the two
hemispheres rather than a higher impairment of the L than R
hemisphere seen in very old animals (Krištofiková et al., 2010).
CHANGES IN NOGO-A-DEFICIENT RATS AND A VALIDITY OF THE
ANIMAL MODEL OF SCHIZOPHRENIA
If we compare our results with those obtained from the autoptic
brain tissue of patients with schizophrenia, we can observe that
neither young nor old Nogo-A-deficient rats displayed cortical
increases in NR2B expression and nNOS activity, especially the
latter in the R side, compared to age-matched controls. On the
other hand, some findings support a validity of this animal model
of schizophrenia.
Accelerated aging in young but not old Nogo-A-deficient rats
If we compare young Nogo-A-deficient rats with age-matched
controls, there is a significant increase in iNOS activity in the L
side (Table 2) and two significant correlation changes (Table 4,
the shifts from negative to positive correlations between NR1 in
the L and nNOS in the R side and between NR2A and eNOS in the
R side). Since these alterations in the cortical NMDAR–NOS path-
way of young Nogo-A-deficient rats are very similar to those of old
controls (despite the changes being only borderline significant in
old controls), the data could be interpreted as accelerated aging
of the young genetically modified animals. On the contrary, old
Nogo-A-deficient rats did not seem to be the model of accelerated
aging. First, we did not observe progressive changes in genetically
modified animals. For example, we did not find in old Nogo-A-
deficient rats the above-mentioned increase in iNOS in the L side
(Table 2) or the alterations in the NR1–nNOS and NR2A-eNOS
pathways (data not shown, p= 0.811 and 0.741, respectively). Sec-
ond, the significant changes observed in old Nogo-A-deficient rats
[i.e., the bilateral increases in NR1 (Table 1) and the shift from a
negative to positive correlation between eNOS and iNOS in the R
side (Table 4)] were opposite to those involved in normal aging.
It is well known that schizophrenia and Alzheimer disease are
both accompanied by progressive cognitive decline and that some
of the changes in brain biochemistry associated with synaptic func-
tions and apoptosis are very similar (Krištofiková et al., 2008; Tang
et al., 2009). For instance, the activities of NOS isoforms in the
hippocampi are increased in schizophrenia and Alzheimer dis-
ease; however, they are more marked in the R side of psychotic
patients and in the L side of people with dementia (Krištofiková
et al., 2008). The identical changes in the NMDAR–NOS pathway
occurring in the cortex of young Nogo-A-deficient rats and old
controls support the hypothesis that schizophrenia is a syndrome
of accelerated aging (e.g., Kirpatrick et al., 2008). On the other
hand, differences between young and old Nogo-A-deficient rats
agree well with studies reporting similar changes in the frontal cor-
tex of patients at early stages of schizophrenia and older controls,
but totally different changes in older psychotic patients at later
stages of the disease (Tang et al., 2009). Our data are also consistent
with non-progressive changes in the cortex in schizophrenia dur-
ing aging, showing that pathological processes occur in a relatively
limited period of time around the onset of illness (Kubota et al.,
2011). We believe that the simple age-dependent progression of
changes in the pathways related to synaptic functions or apoptosis
should be a characteristic sign of neurodegenerative Alzheimer dis-
ease, which incidentally is associated with Nogo-A overexpression
in senile plaques (Gil et al., 2006), but not of neurodevelopmen-
tal schizophrenia. Moreover, we postulate that evaluations of new
models of neurodevelopmental diseases should be performed in
early adolescent as well as late senescent animals to distinguish
among early and late developmental changes (see also Rapoport
et al., 2005).
Alterations in the NMDAR-NOS pathway occurring in the R
hemisphere
As previously described, the increases in nNOS/iNOS activity are
more marked in the R than L hippocampus of patients with
schizophrenia (Krištofiková et al., 2008). Although the data from
Nogo-A-deficient rats did not directly indicate more changes in
the NMDAR–NOS pathway in the R side [see the increase in iNOS
activity in the L side of young rats (Table 2) and the bilateral
elevation of NR1 expression in old rats (Table 1)], our corre-
lation analysis results focused attention on the R side (Table 4).
First, neither young nor old Nogo-A-deficient rats displayed signif-
icant changes exclusively in the L side. Second, we discovered three
statistically significant changes, one of which involved both hemi-
spheres (the shift from negative to positive correlation between
NR1 in the L and nNOS in the R side of young Nogo-A-deficient
rats, which could be interpreted as a disruption of the regulatory
mechanisms between the R and L sides in the NR1–nNOS pathway,
similar to that seen in normal aging) and the remaining two were
exclusively associated with the R side (the shifts from mildly neg-
ative to markedly positive correlations between NR2A and eNOS
in young animals and between eNOS and iNOS in old animals).
For a comparison, no corresponding changes were found in the L
side (data not shown, Rao test for young animals: p= 0.224, that
for old animals: p= 0.603).
With regard to the R hemisphere, data obtained from young
Nogo-A-deficient rats without marked changes in NR2A expres-
sion or eNOS activity could be interpreted as an increased coop-
eration between NR2A and eNOS. It is important to note that
NR2A overexpression has been found, e.g., in the prefrontal cor-
tex of rats reared in isolation, i.e., in animals exhibiting several
characteristics seen in schizophrenia (Turnock-Jones et al., 2009).
Data from old Nogo-A-deficient rats without pronounced changes
in eNOS and iNOS activities could be similarly interpreted as an
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increased cooperation between eNOS and iNOS. This is supported
by studies reporting a stimulation of iNOS transcription in vivo by
activated eNOS (Connelly et al., 2005). Our results thus indicate
the enhanced role of eNOS especially in the R cortex of young or
old Nogo-A-deficient rats.
Abnormal frontoparietal cortex interactions
It is well known that the frontoparietal cortical network for
rapid visual information processing requires working memory.
It is suggested that this network in the R side is specialized for
sustained attention and in the L side, for phonological loop com-
ponent of working memory. In patients with schizophrenia, data
suggest prefrontal-parietal functional disconnections, particularly
prefrontal dissociation and abnormal prefrontal–parietal corti-
cal interaction, during working memory processing (Kim et al.,
2003). In Nogo-A-deficient young and old rats, we did not find
changes in correlations among particular NMDAR subunits, sug-
gesting a possible prefrontal dissociation (Table 4). However,
significant alterations in correlations between NMDAR subunits
in the frontal cortex and NOS isoforms in the parietal cor-
tex could indicate abnormal frontoparietal interactions. After a
Bonferroni correction, there were two corresponding alterations
only in young Nogo-A-deficient rats (the shifts from negative
to positive correlations between NR1 in the L and nNOS in
the R side and between NR2A and eNOS in the R side, see
Table 4). Although we did not find similar significant changes
in old genetically modified animals, some results displayed bor-
derline significance here (e.g., correlations between NR1 in the
R side and iNOS laterality, between NR1 laterality and iNOS
in the R side and between NR1 laterality and iNOS lateral-
ity, see Table 4). Thus, possible abnormal frontoparietal cortex
interactions should not be excluded in young as well as old
Nogo-A-deficient rats.
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